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Introduction
Podocytes are polarized epithelial cells that are critical for the 
renal glomerular filtration barrier through their interdigitated foot 
processes. The filtration barrier is responsible for ultrafiltration of 
the blood and ensures that essential plasma proteins are retained. 
Therefore, dysfunction of podocytes is marked by the loss of pro-
teins into the urine. Nephrotic syndrome (NS) is defined as the 
association of proteinuria, hypoalbuminemia, and edema and is 
the most common primary glomerular disease in children. The 
majority of children with NS respond to steroid therapy (steroid- 
sensitive NS [SSNS]). However, more than 20 percent of patients 
will fail to respond to steroid treatment (steroid-resistant NS 
[SRNS]) (1). SRNS inevitably progresses to end-stage kidney dis-
ease (ESKD) within a few years of onset, necessitating dialysis or 
renal transplantation for survival. It accounts for about 15% of all 
ESKD in children and has a 30% recurrence risk in renal trans-
plants, leading again to ESKD (2). Monogenic mutations in 1 of 27 
genes lead to SRNS. We have recently shown in a cohort of 1,700 
families with SRNS that 30% of all cases are caused by mutations 
in one of these genes (3). Interestingly, most of the encoded gene 
products localize to podocytes, further confirming that podocytes 
are essential for maintaining the glomerular filtration barrier.
Drosophila pericardial nephrocytes are functionally analogous 
to human glomerular podocytes (4). Both cell types form highly 
specialized filtration structures called the “slit diaphragm” as 
well as the basement membrane. Both structures serve as the pri-
mary size- and charge-dependent filtration barriers. The function 
of pericardial nephrocytes can be readily monitored by assaying 
the filtration and uptake of secreted fluorescent proteins from 
the Drosophila hemolymph. This functional assay, in concert with 
nephrocyte-specific Gal4 drivers and RNAi transgenic libraries for 
individual Drosophila genes, makes it possible to screen and iden-
tify genes required for nephrocyte function (5). Previous studies 
have shown that many genes important for podocyte functions are 
also essential for nephrocyte function. The gene products include 
nephrin, NEPH1, and podocin at the slit membrane structures 
(4–6); ADCK4 in mitochondria function (7); and RHO GDI in 
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ankyrin repeat-containing protein 2 (KANK2) in two families with 
NS. In addition, we also discovered rare mutations in the related 
genes KANK1 and KANK4 in families with NS. KANK proteins are 
characterized by conserved ankyrin-repeat and coiled-coil domains 
and a motif (KN motif) at the N-terminus containing potential 
motifs for nuclear localization and export signals (8). In parallel, we 
the regulation of small GTPases (1). Many genes identified from 
Drosophila nephrocyte phenotypic screens have highly conserved 
human homologs that may play similar roles in podocytes (5).
To identify additional genes mutated in NS, here we performed 
homozygosity mapping (HM) and whole-exome sequencing (WES) 
in individuals with NS. We identified recessive mutations in kidney 
Figure 1. HM and WES identify genetic variants in the KANK1, KANK2, and KANK4 genes in families with NS. (A, C, and E) Nonparametric lod scores 
(NPL) are plotted across the human genome. The x axis shows SNP marker positions on human chromosomes concatenated from p-ter (left) to q-ter 
(right). Genetic distance is given in cM. Maximum nonparametric lod score peaks indicate candidate regions of homozygosity by descent. (B, D, and F) 
Gene symbol (underlined), family number, variant, and predicted translational changes are given. Sequence traces are shown for the variant above normal 
control. Mutated nucleotides are indicated by arrowheads. (A) HM of an individual (A982-21) with SSNS. KANK2 is positioned (arrowhead) on chromosome 
19 within one of the homozygous candidate regions. (B) Chromatogram of a KANK2 mutation identified in a family (A982) with SSNS (see also Table 1). (C) 
HM of an individual (A1389-21) with SSNS. KANK1 is positioned (arrowhead) on chromosome 9. (D) Chromatogram of a KANK1 variant identified in family 
A1389 (see also Table 1). (E) HM of an individual (A1436-24) with SRNS. KANK4 is positioned (arrowhead) with a homozygous region on chromosome 1. (F) 
Chromatogram of a KANK4 variant identified in family A1436 (see also Table 1).
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the Exome Variant Server ([EVS] http://evs.gs.washington.edu/
EVS/). To discover additional mutations in KANK2, we performed 
exon resequencing of all 11 KANK2 exons using a high-throughput 
technique harnessing barcoded multiplex PCR and next-genera-
tion sequencing (10) in an additional 576 individuals with SSNS 
and 542 individuals with SRNS. In an individual with SSNS (A1751-
21), we detected a homozygous missense mutation (c.2051C>T;p.
S684F) in exon 9 of KANK2 (Table 1 and Supplemental Figure 1B). 
This variant is absent from the EVS and is predicted to be dele-
terious to protein function by publically available software pro-
grams (Table 1). For exclusion of known genetic causes of SRNS, 
27 known genes previously linked to SRNS were screened in this 
individual, but no explanatory mutations were detected.
HM in an Arab family (A1389) yielded segments of homozygos-
ity by descent with a cumulative genomic length of approximately 
256 Mb (Figure 1C). Following variant filtering by HM and WES, 
4 rare missense variants in KANK1, SOCS5, TBC1D2B, and GRIP1 
remained (Supplemental Table 1). Mutations in the 27 known SRNS 
genes were excluded by evaluation of the WES data. The variant 
(c.1360G>A;p.E454K) in KANK1 (RefSeq accession NM_015158.3) 
was absent from >6,500 controls in the EVS (Figure 1D and Table 
1). We examined an additional 576 individuals with SSNS and 542 
individuals with SRNS to identify additional mutations in KANK1; 
however, we could not discover any additional mutation.
In a family from Slovakia, one child (A1436-24) and her 
maternal cousin’s grandchild (B324-21) had early-onset SRNS 
(Supplemental Figure 1C and Table 1). The renal histologies of 
identified what we believe to be a novel Drosophila gene, CG10249, 
as relevant for Drosophila nephrocyte function. This gene encodes 
a protein containing a KN motif, a coiled-coil motif, and 3 ankyrin 
repeats, similar to the domain composition of the 4 human KANK 
proteins. Therefore, we named it dKank. Here, we show that the 
KANK family genes are required for podocyte function in cultured 
podocytes, Drosophila nephrocytes, and zebrafish, suggesting that 
the KANK family genes play evolutionarily conserved roles in podo-
cyte function and in the pathogenesis of NS.
Results
Mutations in KANK2 cause NS in humans. To identify additional 
genes mutated in NS, we performed HM followed by WES in 
families with NS. In a family (A982) of Arab origin, 2 siblings had 
early-onset SSNS with renal histology of minimal change disease 
(Supplemental Figure 1A; supplemental material available online 
with this article; doi:10.1172/JCI79504DS1). HM of one affected 
sibling (A982-21) yielded 14 regions of homozygosity by descent 
as candidate regions for a recessive mutation (Figure 1A). Follow-
ing WES and filtering of variants from normal reference sequence 
(9), we detected a homozygous missense mutation (c.541A>G;p.
S181G) in KANK2 (RefSeq accession NM_015393.6) on chro-
mosome 19 (Figure 1B and Table 1). This variant was the only 
homozygous variant remaining from evaluation of the WES data 
(Supplemental Table 1) and segregated in a recessive way with the 
affected status in the family. In addition, this variant was absent 
from >6,500 controls (from 13,000 control chromosomes) in 
Table 1. Rare variants identified in KANK1, KANK2, and KANK4 in individuals with NS
Family-
individual
Ethnic 
origin
Nucleotide 
alterationA
Deduced 
protein 
change
Exon 
(segregation)
Amino acid  
sequence 
conservation
MutTB Poly-
Phen2C
SIFTD Age at  
onset
Kidney  
disease
Histology  
(at age)
Extrarenal 
manifestations
KANK1
A1389-21 Arabic c.1360G>A p.E454K 3 (Hom, ND) D. rerio DC  
(1.00)
Dam 
(0.99)
Tol  
(0.11)
3 yr SSNS MCNS (3 yr) ID
KANK2
A982-21 Arabic c.541A>G p.S181G 4 (Hom, M, F) X. tropicalis SNP 
(0.96)
Dam 
(0.57)
Tol  
(0.45)
3 yr SSNS MCNS (12 yr) –
A982-22 Arabic c.541A>G p.S181G 4 (Hom, M, F) X. tropicalis SNP 
(0.96)
Dam 
(0.57)
Tol  
(0.45)
2 yr SSNS MCNS (12 yr) –
A1751-21 European c.2051C>T p.S684F 9 (Hom, ND) D. rerio DC  
(1.00)
Dam 
(0.98)
Del  
(0.00)
3 yr SDNS, HU MCNS (4 yr) –
KANK4
A1436-24 European c.2401T>CE p.Y801H 7 (Hom, M, F) D. melanogaster DC  
(1.00)
Ben 
(0.04)
Del  
(0.01)
2 mo SRNS, HU FSGS (4 yr) ID, short stature, 
facial dysmorphism, 
ASD, dilative CMP
B324-21F European c.2401T>CE p.Y801H 7 (Hom, M, F) D. melanogaster DC  
(1.00)
Ben 
(0.04)
Del  
(0.01)
2 mo SRNS, HU FSGS (2 mo) ID, facial 
dysmorphism, ASD, 
leukocytosis
AKANK1, KANK2, and KANK4 cDNA mutations are numbered according to human cDNA reference sequence NM_015158.3, NM_015493.6, and NM_181712.4, 
respectively. BMutationTaster score (range: 0–1.0), 1.0 being most likely. CPolyPhen2 (HumVar) score (range: 0–1.0), 1.0 being most deleterious. DSIFT score 
(range: 0–1.0), 0 being most deleterious. EVariant in dbSNP database (rs145623004); allele frequency in EVS, GG = 0/GC = 8/CC = 6,495, and in Exome 
Aggregation Consortium (http://exac.broadinstitute.org/), 121/120,924 (0.001), only heterozygously. FB324-21 is a maternal cousin of A1436-24. ASD, atrial 
septal defect; Ben, benign; CMP, cardiomyopathy; Dam, possibly damaging; DC, disease causing; F, heterozygous mutation identified in father; FSGS, focal 
segmental glomerulosclerosis; Hom, homozygous in affected individual; HU, hematuria; ID, intellectual disability; M, heterozygous mutation identified in 
mother; MCNS, minimal change NS; MutT, MutationTaster; ND, no data; SDNS, steroid-dependent NS; Tol, tolerated.
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plasm of kidney cell lines (8). Because most of products of genes 
that cause NS if mutated are localized to podocytes, we examined 
localization of KANK1, KANK2, and KANK4 in adult rat kidney 
sections. In glomeruli, KANK1 was predominantly expressed in 
podocytes, as identified by the expression of nuclear WT1 (Fig-
ure 2A and Supplemental Figure 2A). KANK1 partially colocal-
ized with synaptopodin, which regulates RHOA signaling (Figure 
2A and ref. 11). For KANK2, a previous study showed that Kank2 
mRNA is enriched in glomeruli rather than tubules in the mouse 
kidney and that KANK2 partially colocalizes with synaptopodin, 
but not with endothelial marker CD31, in human adult kidney (12). 
KANK2 localized to podocyte cell bodies as well as nuclei in rat 
glomeruli (Figure 2B and Supplemental Figure 2B). KANK pro-
teins contain a KN motif, which includes potential nuclear local-
ization and export signals (8), and were shown to shuttle between 
the nucleus and the cytoplasm via a process mediated by nuclear 
localization and export signals (13). KANK4 localized to podocyte 
cell bodies and primary processes (Figure 2C and Supplemental 
Figure 2C). KANK2 and KANK4 did not show any colocalization 
with synaptopodin (Figure 2, B and C). To investigate whether 
mutation of KANK proteins present in individuals with NS leads to 
a change in their subcellular localization, we performed immun-
ofluorescence in cultured human podocytes upon overexpression 
(Supplemental Figure 3). However, none of the variant proteins 
exhibited any difference in subcellular localization compared with 
that of wild-type KANK proteins.
dKank is required for Drosophila cardiac nephrocyte function 
and cytoskeleton structure. From a functional genetic screen for 
Drosophila cardiac nephrocytes, we identified a gene we believe 
to be novel, CG10249. This gene encodes the unique KANK 
family protein in Drosophila. Therefore, we named it dKank. 
The dKank protein contains a KN motif, a coiled-coil motif, and 
3 ankyrin repeats, similar to the domain composition of the 4 
human KANK proteins. Compared with wild-type nephrocytes 
(Figure 3, A and B), RNAi knockdown of dKank in nephrocytes 
substantially reduced the fluorescent protein uptake (as shown 
by red fluorescent protein fused with the atrial natriuretic factor 
[ANF-RFP] signal, Figure 3C) of cardiac nephrocytes, whereas 
the number and size of the cardiac nephrocytes remained the 
same (Figure 3D), as indicated by Hand-GFP labeling (green). 
Another independent RNAi line for dKank was tested to con-
firm that dKank is required for nephrocyte function. Significant 
reduction of fluorescent protein uptake was observed for both 
RNAi lines for dKank (Supplemental Figure 4). To examine in 
detail the exact roles of dKank in nephrocyte cellular function 
and structure, we performed transmission electron microscopy 
(TEM) analysis on third instar Drosophila larvae cardiac nephro-
A1436-24 and of B324-21 revealed focal segmental glomeru-
losclerosis (Supplemental Figure 1, D and E). HM in individu-
als A1436-24 and B324-21 yielded regions of homozygosity by 
descent with cumulative genomic lengths of approximately 228 
Mb and 370 Mb, respectively (Figure 1E and Supplemental Table 
1). Following variant filtering by HM and WES, two rare variants 
in KANK4 and THBS3 remained, and both variants segregated 
with the affected status in the family (Supplemental Table 1). 
Mutations in the 27 known SRNS genes were excluded by eval-
uation of the WES data. The variant (c.2401T>C;p.Y801H) in 
KANK4 (RefSeq accession NM_0181712.4) is reported as a SNP 
in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/
SNP/); however, its minor allele frequency is less than 0.004, 
and it never occurred in the homozygous state (Figure 1F and 
Table 1). The KANK4 variant is predicted to be deleterious to 
protein function by publically available software programs and 
alters an amino acid residue conserved throughout evolution 
down to Drosophila melanogaster (Table 1).
Thus, our discovery of mutations in the KANK family genes 
by independent HM and WES provided genetic support for patho-
genic roles of this group of proteins in NS. The KANK family pro-
teins, KANK1–KANK4, are characterized by their unique struc-
ture, coiled-coil motifs in the N-terminal region, ankyrin repeats 
in the C-terminal region, and an additional motif, the KN motif, 
at the N-terminus (8).
KANK1, KANK2, and KANK4 localize to podocytes in glomer-
uli. KANK family proteins are localized prominently to the cyto-
Figure 2. KANK1, KANK2, and KANK4 localize to podocytes in rat glomer-
uli. (A) Coimmunofluorescence of KANK1 with podocyte marker proteins in 
rat glomeruli. KANK1 is highly expressed in podocytes, as identified by the 
expression of nuclear WT1. KANK1 partially colocalizes with synaptopodin. 
(B) Coimmunofluorescence of KANK2 with podocyte marker proteins in 
rat glomeruli. KANK2 is expressed in cytoplasm and nuclei of podocytes. 
KANK2 does not colocalize with synaptopodin. (C) Coimmunofluorescence 
of KANK4 with podocyte marker proteins in rat glomeruli. KANK4 localizes 
to podocyte cell bodies and primary processes but does not colocalize with 
synaptopodin. Scale bar: 25 μm.
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circles) as well as a reduced number of 
vacuoles and lysosomes (Figure 3F). 
High-magnification images showed 
that the surface of the cardiac neph-
rocyte upon knockdown was not as 
even and flat as that of wild-type 
nephrocytes (Figure 3, G and H), and 
marked gaps can be seen between the 
wave-shaped plasma membrane and 
the basement membrane of the neph-
rocytes with dKank RNAi (Figure 3H, 
arrows). A closer look at the slit dia-
phragm filtration structures showed 
that the evenly distributed slit dia-
phragm in wild-type nephrocytes (Fig-
ure 3I, arrows) was absent from neph-
rocytes with dKank RNAi (Figure 3J). 
In summary, compared with wild-type 
nephrocytes (Figure 3, G and I), lack 
of dKank led to uneven distribution 
of lacuna channels along the plasma 
membrane surface (Figure 3H) and 
abnormal lacuna shape (Figure 3J).
Knockdown of kank2 in zebrafish 
results in proteinuria. Because we have 
identified mutations in KANK2 in 
two families with NS, we performed 
knockdown of the KANK2 ortholog in 
zebrafish to further examine the role 
of KANK2 for glomerular function. 
Zebrafish kank2 has 48% amino acid 
sequence identity to human KANK2. 
A p53 morpholino oligonucleotide 
(MO) is known to reduce the cell 
death induced by off-target effects 
of MOs (14), and injection of p53 MO 
alone did not produce any phenotype 
in zebrafish (Figure 4A and Supple-
mental Table 2). Upon knockdown of 
kank2 by a MO targeting the transla-
tion initiation site of zebrafish kank2 
(ATG MO), we observed periorbital 
edema and total body edema in 54.5% 
of larvae at 120 hours after fertiliza-
tion, reminiscent of signs of NS in 
humans (Figure 4B). Similar results 
were obtained with a MO targeting 
the donor site of exon 2 (e2i2) of kank2 
(periorbital edema and total body 
edema in 52.3% of larvae at 120 hours after fertilization) (Figure 
4C and Supplemental Figure 5A). The proteinuric effect of both 
kank2 e2i2 and ATG MOs was confirmed using an established 
zebrafish proteinuria assay (15) by ELISA against a fusion pro-
tein of vitamin D–binding protein (VDBP) and GFP in I-fabp:: 
VDBP-GFP transgenic zebrafish (Figure 4D).
We then performed TEM imaging of zebrafish pronephric 
glomeruli to permit a more direct evaluation of a nephrosis phe-
cytes following dKank RNAi knockdown. Compared with wild-
type nephrocytes (Figure 3, E, G, and I), dKank RNAi in cardiac 
nephrocytes led to uneven distribution of endocytic vacuoles 
and lacuna channels (Figure 3F). Wild-type cardiac nephrocytes 
showed evenly distributed and layered vesicles and vacuoles 
as well as a large number of lysosomes (Figure 3E, arrows). In 
contrast, cardiac nephrocytes with dKank RNAi showed dimin-
ished lacuna structures in many areas (Figure 3F, yellow dashed 
Figure 3. dKank is required for Drosophila cardiac nephrocyte function and cytoskeleton structure. (A 
and B) Control Drosophila larvae carrying myosin heavy chain promoter–driven ANF-RFP (red), which is 
secreted from muscles into hemolymph and then filtered and taken up by cardiac nephrocytes. Hand-
GFP labels the nuclei of nephrocytes. (C) Nephrocytes with dKank RNAi knockdown using Dot-Gal4 
(Dot>dKank-IR) show substantially reduced uptake of ANF-RFP, (D) whereas the number and size of 
nephrocytes remain the same as those of wild-type nephrocytes. (E) Control third instar Drosophila larvae 
nephrocytes show evenly distributed vesicles (arrows) and vacuoles in distinct layers of cytoplasm. (F) 
Nephrocytes with dKank RNAi exhibit uneven distribution of endocytic vacuoles and lacuna channels, 
with reduced numbers of vesicles and vacuoles in some areas (yellow circles) but increased vesicles 
and vacuoles in other areas as well as reduced numbers of lysosomes. (G) High-magnification image 
of control nephrocytes showing even and flat plasma membrane and adjacent basement membrane. 
(H) Nephrocytes with dKank RNAi show wave-shaped plasma membrane surface and gaps between 
the plasma membrane and the basement membrane (arrows). Distribution of lacuna channels close to 
the nephrocyte cell surface is disrupted. (I) High-magnification images of control nephrocytes showing 
evenly distributed electron-dense slit diaphragm (arrows) and lacuna channel structures. (J) Nephrocytes 
with dKank RNAi show wave-shaped plasma membrane surface, without slit diaphragm structures and 
abnormally shaped lacuna channels. Original magnification, ×20 (A–D). Scale bar: 4 μm (E and F); 1 μm (G 
and H); 0.2 μm (I and J).
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notype on the subcellular level. When compared with p53 MO–
injected controls (Figure 4E and Supplemental Figure 5B), we 
observed characteristic alterations of nephrosis upon knockdown 
of kank2 (Figure 4F and Supplemental Figure 5, C and D). These 
included podocyte foot process effacement and disorganization, 
rarefaction of slit membranes, and disorganization of the glom-
erular basement membrane in zebrafish glomeruli (Figure 4F) as 
previously described in plce1 knockdown (16).
To test the pathogenicity of the identified mutations, we 
injected synthetic mRNA containing KANK2 missense mutations 
into zebrafish with kank2 e2i2 MO. Injection of wild-type human 
KANK2 mRNA partially rescued the edema phenotype (Figure 
4G). In contrast, both mutant mRNAs failed to rescue the kank2 
morphant phenotype (Figure 4G), indicating that these mutations 
cause loss of function.
KANK2 interacts with ARHGDIA. As knockdown of kank2 
resulted in a nephrosis phenotype in zebrafish larvae, we fur-
ther examined KANK2 expression in glomeruli of adult rat kid-
neys. In cytoplasm and nuclei of podocytes, KANK2 partially 
colocalized with ARHGDIA and PLCE1, two proteins of which 
genes are mutated in human NS (Figure 5A and refs. 1, 16). In 
addition, we found that KANK2 also partially colocalized with 
the RHO small GTPase RHOA in podocytes (Figure 5A). As 
KANK2 partially colocalized with ARHGDIA and RHOA and 
as we have previously shown that the protein complex precip-
itated by ARHGDIA in rat glomerular lysates includes RHOA, 
RAC1, and CDC42 (1), we examined whether this protein com-
plex includes KANK2. We performed coimmunoprecipitation 
experiments using rat glomerular lysates. The anti-ARHGDIA 
antibody coimmunoprecipitated KANK2 as an interaction part-
ner and also coimmunoprecipitated RHOA as previously shown 
(Figure 5B and ref. 1). We then performed coimmunoprecip-
itation in cultured human podocytes to examine whether the 
KANK2 variant (p.S181G), which we detected in the two siblings 
with NS of family A982, affects protein-protein interaction. The 
missense KANK2 variant showed stronger binding affinity to 
ARHGDIA compared with wild-type KANK2 when coexpressed 
and coimmunoprecipitated in cultured podocytes (Supplemen-
tal Figure 6A). We confirmed this finding by GST pull-down 
assay using lysates of podocytes transfected with WT KANK2 or 
p.S181G KANK2 (Supplemental Figure 6B). Interestingly, when 
KANK2 p.S181G was present, the binding affinity of ARHGDIA 
to RHOA, RAC1, and CDC42 seemed to be increased (Supple-
mental Figure 6, A and B). These data suggest that KANK2 may 
be related to RHO GTPase function, analogous to the regulation 
of RHOA by KANK1 via 14-3-3 (17).
KANK2 knockdown in cultured podocytes causes increased levels 
of active RHOA and a decreased migratory phenotype. Previously, 
we have shown that mutations in ARHGDIA cause monogenic 
NS and that they change in the active states of RHO GTPases (1). 
Figure 4. Functional analysis of kank2 knockdown in zebrafish. (A) Control zebrafish injected with p53 MO. p53 MO did not produce any phenotype 
until 168 hours after fertilization (n > 100). (B) Zebrafish coinjected with a MO targeting the translation initiation site of zebrafish kank2 (ATG MO) and 
p53 MO. At 120 hours after fertilization, kank2 morphants display the nephrosis phenotype of periorbital edema (arrows) and body edema in 54.5% of 
embryos (113 of 207). (C) Zebrafish coinjected with a MO targeting exon 2 splice donor site of kank2 (e2i2 MO) and p53 MO. e2i2 MO causes edematous 
phenotypes (arrows) in 52.3% of embryos (243 of 464). (D) Proteinuria assay in I-fabp::VDBP-GFP transgenic zebrafish. Note that knockdown of kank2 by 
either e2i2 or ATG MO causes significant proteinuria compared with that in control fish. (E and F) Electron microscopic structure of glomerular base-
ment membrane and podocyte foot processes in 5-day-old (E) control and (F) kank2 morphant zebrafish. In the control, the foot processes are regularly 
spanned by slit diaphragms (arrows). In contrast, the foot processes of morphants are effaced and disorganized, with only occasional intercellular 
junctions (arrows in F). The glomerular basement membrane is disorganized. (G) Functional analysis of KANK2 mutations in zebrafish. Coinjection of 
kank2 e2i2 MO with a human wild-type KANK2 mRNA (156 of 491) partially rescued edematous phenotypes of kank2 morphants, whereas injection of 
KANK2 mRNA bearing the p.S181G (277 of 623) or p.S684F (187 of 447) mutation failed to rescue the phenotype. Error bars indicate the SD of more than 
3 independent experiments. *P < 0.05, 2-tailed Student’s t test. Scale bar: 1 mm (A–C); 1 μm (E and F).
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Here, we showed that KANK2 interacts with the RHO GTPase 
regulator ARHGDIA. To test whether KANK2 is also involved in 
RHO GTPase signaling, we performed knockdown of KANK2 in 
cultured human podocytes. We used purified rhotekin to assay 
the active GTP-bound state of RHOA and used purified PAK1 
to assay the active states of RAC1 and CDC42. Knockdown of 
KANK2 increased the GTP-bound form of RHOA (Figure 6A) 
but had no effect on RAC1 or CDC42 (Figure 6B). To test the 
pathogenicity of the identified mutations, we overexpressed 
wild-type and mutant KANK2 proteins in murine cultured podo-
cytes. Regardless of whether wild-type or mutant protein was 
used, overexpression of KANK2 in itself did not change RHOA 
activity (Supplemental Figure 7A). However, similar to human 
cultured podocytes, knockdown of Kank2 resulted in increased 
active RHOA in murine podocytes (Supplemental Figure 7B). 
This increased RHOA activity was reversed by overexpression of 
wild-type KANK2 but not by overexpression of KANK2 p.S181G 
or p.S684F (Supplemental Figure 7B), suggesting that both muta-
tions cause loss of function regarding the regulation of RHOA. 
Human KANK2 was resistant to Kank2 siRNAs used in this exper-
iment (Supplemental Table 2). We then examined the effect of 
KANK2 on podocyte migration and found that knockdown of 
Kank2 in murine cultured podocytes caused a decreased migra-
tory phenotype (Figure 6C), which was reversed by overexpres-
sion of human KANK2. In contrast, overexpression of KANK2 
p.S181G failed to rescue the decreased migratory phenotype 
caused by Kank2 knockdown, whereas overexpression of KANK2 
p.S684F resulted in partial rescue, indicating that this mutation is 
potentially hypomorphic in migration (Figure 6C).
Furthermore, we examined whether KANK1 and KANK4 
have effects on active states of RHO GTPases. Similar to KANK2, 
knockdown of KANK1 in cultured podocytes increased active 
RHOA and RAC1 but not CDC42 (Supplemental Figure 8). This 
is consistent with previous studies that have shown that knock-
down of KANK1 in HeLa cells increases RHOA-GTP (17) and that 
KANK1 specifically inhibits the binding of IRSp53 with active 
RAC1 but not with active CDC42 (18). In contrast, knockdown of 
KANK4 in podocytes did not have any effect on the active states 
of RHOA, RAC1, and CDC42 (data not shown). In the podocyte 
migration assay, knockdown of KANK1 resulted in decreased 
migration, whereas knockdown of KANK4 did not change the 
migratory phenotype of podocytes compared with that of control 
podocytes (data not shown).
Discussion
Here, we described the function of KANK proteins in podocytes 
and we identified genetic mutations in the KANK family genes in 
families with NS by the combined approach of WES and HM. We 
showed that KANK1, KANK2, and KANK4 localize to podocytes 
in glomeruli and regulate RHO GTPase activity. Knockdown of 
KANK1 and KANK2 in podocytes resulted in increases of the 
GTP-bound form of RHOA and reduced their migratory pheno-
type. By functional screen in Drosophila nephrocytes and knock-
down of kank2 in zebrafish, we demonstrated that the function of 
this gene is required for proper podocyte function. TEM analysis 
of both Drosophila and zebrafish showed that knockdown of kank 
genes led to disrupted slit diaphragm filtration structures, sug-
gesting that in both model systems the kank genes are required 
for normal cytoskeleton structure, which in turn is required for 
the formation of slit diaphragm filtration structures. In addition, 
the identification of both rhoGDI and kank from the functional 
genetic screen in Drosophila cardiac nephrocytes indicates that 
these genes may play evolutionarily conserved roles in the func-
tion of nephrocytes and podocytes (1).
KANK was originally identified in a genomic region, show-
ing a loss of heterozygosity in renal cell carcinoma. Reduced 
or loss of expression of KANK1 was observed in renal cell car-
cinoma tissues and cell lines, and overexpression of KANK1 
resulted in disorganization of β-actin distribution in G-402 cells 
(19). KANK1 is known to regulate actin polymerization and cell 
migration, and this function of KANK1 is mediated through two 
signaling pathways: the regulation of RHOA activity through 
phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling (17) and 
the regulation of RAC1 signaling by inhibition of IRSp53 (18). In 
this study, we showed that KANK2, as well as KANK1, regulates 
RHO GTPases and cell migration in podocytes and that KANK2 
is in a complex with ARHGDIA.
We have identified by HM and WES mutations in KANK1 and 
KANK4 in a family with NS. It appears that mutation of KANK1 or 
KANK4 represents a very rare cause of NS, as screening of more 
than 1,100 individuals with NS using a high-throughput muta-
tion analysis failed to identify any additional mutation in KANK1 
Figure 5. KANK2 colocalizes with and interacts with ARHGDIA in rat 
glomeruli. (A) Coimmunofluorescence of KANK2 with PLCE1, ARHGDIA, 
and RHOA. KANK2 partially colocalizes with PLCE1 and ARHGDIA, which are 
associated with NS. Anti-PLCE1 and anti-ARHGDIA antibodies were directly 
fluorescently labeled with Alexa Fluor 547. KANK2 also partially colocalizes 
with RHOA in rat glomeruli. Scale bar: 25 μm. (B) Coimmunoprecipitation of 
KANK2 in rat renal glomerular lysates. The protein complex precipitated by 
an anti-ARHGDIA antibody includes KANK2 as well as RHOA.
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inactive (GDP-bound) states is regulated by 3 sets of proteins: 
quinine nucleotide-exchange factors, GTPase-activating pro-
teins, and guanine nucleotide-dissociation inhibitors (24). It has 
been shown that aberrant RHO GTPase signaling in podocytes 
results in proteinuria in humans and animal models (1, 25–30). 
Knockdown of KANK1 and KANK2 in cultured podocytes led to 
an increase in the GTP-bound form of RHOA. Previously, it was 
demonstrated that transgenic mice, which overexpress consti-
tutively active RhoA in podocytes, exhibit foot process efface-
ment and proteinuria (26). Our current data from Drosophila, 
zebrafish, and human patients demonstrate that KANK fam-
ily proteins have essential roles in podocyte/nephrocyte func-
tion and regulate RHO GTPase activity. Because NS caused by 
KANK variants is due to dysregulation of RHO GTPase activity, 
it is worth considering that this genetic form of NS, due to muta-
tions in the KANK family genes, may be treated with drugs that 
inhibit or promote RHO GTPase activity. Depletion of KANK4 
in podocytes did not change the activity of RHO GTPases or cell 
migration, so the function of KANK4 in podocytes may be dif-
ferent from that of KANK1 or KANK2.
or KANK4. This is consistent with the finding that some of the 
recently identified recessive genetic causes of NS are exceedingly 
rare (1, 20, 21). In addition, we identified two families with NS 
with KANK2 variants. Recently, Ramot et al. identified a homozy-
gous missense mutation (p.A670V) in KANK2 in two families 
presenting with keratoderma and wooly hair and showed that 
localization of NCOA3 (SRC-3) was changed in individuals with 
p.A670V KANK2 mutation (22). Therefore, we have examined 
whether the identified mutations in KANK2 affect interaction 
with NCOA3. None of the KANK2 mutations identified in indi-
viduals with NS abrogated the interaction with NCOA3 (Supple-
mental Figure 9). Additional identification of genetic variants in 
the KANK family genes is necessary to determine the phenotypic 
spectrum of mutations.
RHO GTPases are key regulators of cytoskeletal dynamics 
in a wide range of cellular processes, including cell adhesion, 
migration, and cell division (23). RHO GTPases are tightly reg-
ulated, so at any given time, only a small fraction of all RHO 
GTPases present in the cell are in the active state (24). The 
cycling of RHO GTPases between active (GTP-bound) and 
Figure 6. Effects of Kank2 knockdown on RHO 
GTPase activity and podocyte migration in cultured 
podocytes. (A) Active GTP-bound RHOA precipitated 
from cultured human podocytes transfected with 
scrambled (Scr) or KANK2 siRNA using a GST-rhot-
ekin (RBD) pull-down (PD) assay. Ponceau red 
staining shows the GST proteins used. Compared 
with control podocytes, podocytes transfected with 
KANK2 siRNA exhibit a relative increase in RHOA. 
The efficiency of knockdown by siRNA was confirmed 
by immunoblotting with an anti-KANK2 antibody. (B) 
Active GTP-bound forms of RAC1 and CDC42 precip-
itated from podocytes transfected with scrambled 
or KANK2 siRNA using a GST-PAK1 (CRIB) pull-down 
assay. Cells transfected with scrambled control 
siRNA versus KANK2 siRNA exhibited no signifi-
cant difference in relative RAC1 and CDC42 activity. 
Pull-down experiments are representative of more 
than 3 experiments. (C) Effect of Kank2 knockdown 
on podocyte migration. Cultured murine podocytes 
transfected with Kank2 siRNA (red) exhibited less 
active migration compared with those transfected 
with scrambled siRNA (black). Decrease in podocyte 
migration by Kank2 knockdown was rescued by over-
expression of human wild-type KANK2 in podocytes 
(green) but not by overexpression of the KANK2 
p.S181G variant (blue). Overexpression of p.S684F 
resulted in partial rescue, indicating that this muta-
tion is potentially a hypomorphic mutation. Error 
bars are shown in only one direction for clarity, and 
the result shown is representative of 3 experiments.
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
2 3 8 3jci.org   Volume 125   Number 6   June 2015
tein A-Sepharose 4B Conjugate (Life Technologies) or EZview Red 
ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich). Fluorescent images 
were obtained with a Leica SP5X laser scanning microscope.
Podocyte migration assay. Real-time migration assay was per-
formed using the xCELLigence system (ACEA Biosciences) in CIM-
plate 16 according to the manufacturer’s instructions. Briefly, 24 hours 
after transfection, 4 × 104 cells were plated in serum-free media in the 
upper chamber. The lower chambers were plated with 10% FBS for 
chemoattraction or with serum-free media. The obtained data were 
analyzed using RTCA software. Results were presented as time versus 
cell index curve.
Zebrafish studies. Zebrafish (Danio rerio) were maintained and 
reared as described previously (15). 0.2 mM MOs were injected into the 
AB* wild-type strain for phenotype analysis of morphants, TEM, and 
drug treatment. The proteinuria assay was performed using I-fabp:: 
VDBP-GFP transgenic fish and the GFP ELISA Kit (Cell Biolabs) as 
described previously (15). For mRNA rescue in zebrafish, the wild-type 
and mutant KANK2-coding region was subcloned into the pCSmCher-
ryDest expression vector (34) using Gateway technology (Invitrogen). 
Capped RNAs were synthesized from linearized vectors using the SP6 
mMessage mMachine Kit (Ambion). RNA products were column puri-
fied with the RNeasy Mini Kit (Qiagen) prior to injection at 25- to 400-
pg doses into 1-cell stage zebrafish embryos. For rescue of morphant 
phenotypes, MOs were injected into 2- to 4-cell embryos that had pre-
viously been injected with RNA.
Statistics. Results are presented as mean ± SEM or SD for the 
number of experiments indicated in figure legends. Statistical analy-
sis of continuous data was performed with 2-tailed Student’s t test or 
Tukey’s multiple comparison test, as appropriate. P < 0.05 was consid-
ered statistically significant.
Study approval. Approval for human subjects research was 
obtained from the University of Michigan and the Boston Chil-
dren’s Hospital Institutional Review Boards. All participants or 
their guardians provided written informed consent. Approval for 
zebrafish research was obtained from the University of Michigan 
and the Boston Children’s Hospital University Committees on Use 
and Care of Animals.
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Methods
Study participants. After obtaining informed consent, clinical data and 
blood samples were obtained from individuals with SRNS or SSNS (see 
Supplemental Methods). The diagnosis of NS was made by (pediatric) 
nephrologists, based on standardized clinical and renal histologic cri-
teria (31). Renal biopsies were evaluated by renal pathologists. Clinical 
data were obtained using a questionnaire provided by Renal Genes, 
Boston Children’s Hospital (http://www.renalgenes.org).
RNAi-based Drosophila nephrocyte functional screen. The func-
tional readout, transgenic flies, and screen strategies were described 
previously (5). The first dKank RNAi line (dKank-IR1, BL-33432) was 
identified from the nephrocyte screen and then verified by another 
independent dKank RNAi line (dKank-IR2, v-15009). ImageJ (version 
1.48) was used to quantify the intensity of the ANF-RFP signal in neph-
rocytes. Threshold was adjusted to each picture to remove the back-
ground first on both ANF-RFP (red) and Hand-GFP (green) channels. 
The ANF-RFP mean intensity in each nephrocyte was normalized by 
the Hand-GFP of the same cell. At least 20 nephrocytes were mea-
sured for each genotype.
TEM analysis of Drosophila cardiac nephrocytes. The protocols and 
reagents were described previously (5, 32).
HM, whole-exome resequencing, and mutation calling. HM, 
whole-exome resequencing, and mutation calling were performed as 
described previously (9).
Plasmids, siRNAs, cell culture, and transfection. Human KANK1 
(GenBank BC037495), KANK2 (BC098105), and KANK4 (GenBank 
BC060866) clones were purchased from Open Biosystems. Mutated 
clones were generated by a PCR-based site-directed mutagenesis 
method. The KANK-specific and control scrambled siRNAs were pur-
chased from GE Dharmacon. The immortalized human podocytes 
were maintained in RPMI plus GlutaMAX-I (Gibco) supplemented 
with 10% fetal bovine serum, 50 IU/ml penicillin/50 μg/ml strepto-
mycin, and insulin-transferrin-selenium-X (33). The immortalized 
murine podocytes were provided by Peter Mundel (Massachusetts 
General Hospital, Boston, Massachusetts, USA) and RPMI plus Glu-
taMAX-I supplemented with 10% fetal bovine serum, 50 IU/ml pen-
icillin/50 μg/ml streptomycin, and IFN-γ (50 U/ml). Plasmids and 
siRNAs were transfected into podocytes grown at the permissive tem-
perature of 33°C using Lipofectamine 2000 (Invitrogen).
Immunoblotting, immunoprecipitation, pull-down assay, and 
immunofluorescence staining. Immunoblotting, immunoprecipi-
tation, pull-down assay, and immunofluorescence staining were 
performed as described previously (1). GST-rhotekin RBD beads 
were purchased from Cytoskeleton Inc. GST-PAK1 CRIB domain 
and GST-ARHGDIA were purified from BL21(DE3) Escherichia coli 
strain. Anti-KANK2 (HPA015643), anti-KANK1 (HPA005539), and 
anti-KANK4 (HPA014030) (Sigma-Aldrich); anti-FLAG (2368S), 
anti-MYC (2276S), and anti-BiP (3177S) (Cell Signaling Technology); 
anti-RAC1 (610650) and anti-CDC42 (610928) (BD Transduction 
Laboratories); anti-ARHGDIA (sc-360), anti-RHOA (sc-418), and 
anti-V5 (sc-83849-R) (Santa Cruz Biotechnology); and anti-synap-
topodin (American Research Products) were purchased from com-
mercial sources. Anti-PLCE1 antibody was previously described by 
Hinkes et al. (16). Anti-ARHGDIA and anti-PLCE1 antibodies were 
labeled with the APEX Alexa Fluor Labeling Kit (Life Technologies). 
Alexa Fluor 488 Phalloidin (A12379) was purchased from Life Tech-
nologies. Coimmunoprecipitation was performed using rec-Pro-
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